Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 18, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	347,907	293,004	172,366	120,256	157,436	126,468
Market Cap Growth	80.92%	69.99%	43.33%	-23.61%	24.49%	394.20%
Enterprise Value	349,334	287,341	165,176	117,048	156,449	127,128
Last Close Price	909.45	1159.80	676.60	472.70	608.03	483.61
PE Ratio	144.13	109.38	57.40	29.24	34.69	34.90
PS Ratio	27.64	24.47	16.40	8.97	11.93	12.53
PB Ratio	18.90	15.92	8.40	6.93	10.31	10.71
P/TBV Ratio	35.59	29.97	8.67	7.19	10.32	10.73
P/FCF Ratio	-	221.22	51.78	70.21	61.79	46.55
P/OCF Ratio	-	101.68	44.80	26.30	47.71	33.06
EV/Sales Ratio	27.75	23.99	15.71	8.73	11.85	12.59
EV/EBITDA Ratio	98.50	70.85	40.39	20.44	27.00	28.85
EV/EBIT Ratio	129.02	87.58	46.61	22.25	28.89	31.02
EV/FCF Ratio	-	216.94	49.62	68.34	61.40	46.79
Debt / Equity Ratio	0.15	0.15	0.03	0.04	0.06	0.12
Debt / EBITDA Ratio	0.79	0.69	0.16	0.12	0.17	0.32
Debt / FCF Ratio	-	2.11	0.20	0.41	0.38	0.53
Asset Turnover	-	0.45	0.50	0.71	0.80	0.76
Inventory Turnover	-	1.85	1.32	1.87	2.24	2.19
Quick Ratio	-	1.78	8.61	4.17	3.85	1.56
Current Ratio	-	2.43	10.68	6.37	5.36	2.57
Return on Equity (ROE)	-	13.61%	15.86%	25.21%	33.52%	35.78%
Return on Assets (ROA)	-	7.76%	10.50%	17.33%	20.49%	19.35%
Return on Capital (ROIC)	7.99%	9.68%	11.30%	19.18%	22.96%	21.76%
Return on Capital Employed (ROCE)	-	12.30%	16.60%	29.10%	33.40%	32.70%
Earnings Yield	0.69%	0.91%	1.74%	3.42%	2.88%	2.86%
FCF Yield	-	0.45%	1.93%	1.42%	1.62%	2.15%
Dividend Yield	-	-	-	-	0.33%	0.41%
Payout Ratio	-	-	-	49.52%	11.22%	7.03%
Buyback Yield / Dilution	-0.94%	-0.49%	-	-	-	0.00%
Total Shareholder Return	-	-0.49%	-	-	0.33%	0.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.